High aromatase activity and overexpression of epidermal growth factor receptor in fibrolamellar hepatocellular carcinoma in a child

Journal of Pediatric Hematology/Oncology

Volumn 33, Issue 5, 2011, Pages

  Muramori, Katsumi ^a   Taguchi, Syouhei ^a   Taguchi, Tomoaki ^b   Kohashi, Kenichi ^b   Furuya, Keizo ^a   Tokuda, Kiriko ^a   Ishii, Eiichi ^c  

^a EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c EHIME UNIVERSITY   (Japan)

Author keywords

aromatase; epidermal growth factor receptor; Fibrolamellar hepatocellular carcinoma; gynecomastia

Indexed keywords

ANTIBIOTIC AGENT; AROMATASE; C REACTIVE PROTEIN; CISPLATIN; DECARBOXYPROTHROMBIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; FOLLITROPIN; GALLIUM; LUTEINIZING HORMONE; PIRARUBICIN; TESTOSTERONE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHILD; COMPUTER ASSISTED TOMOGRAPHY; ENZYME ACTIVITY; FEVER; GYNECOMASTIA; HEADACHE; HUMAN; IMMUNOHISTOCHEMISTRY; INFECTION; LIVER CELL CARCINOMA; LIVER RESECTION; LYMPH NODE DISSECTION; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; TUMOR CALCINOSIS; TUMOR CELL;

AROMATASE; CARCINOMA, HEPATOCELLULAR; CHILD; GYNECOMASTIA; HUMANS; LIVER NEOPLASMS; MALE; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 79959818299     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3182011676     Document Type: Article

References (21)

1. Torbenson M. Review of the clinicopathologic features of fibrolamellar carcinoma. Adv Anat Pathol. 2007;14:217-223. (Pubitemid 46659192)
2. Stipa F, Yoon SS, Liau KH, et al. Outcome of patients with fibrolamellar hepatocellular carcinoma. Cancer. 2006;106: 1331-1338. (Pubitemid 43363911)
3. Hernandez-Castillo E, Mondragon-Sanchez R, Garduno- Lopez AL, et al. Hepatocellular carcinoma in the youth. A comparative analysis with hepatocellular carcinoma in adulthood. Hepatogastroenterology. 2005;52:903-907. (Pubitemid 40834629)
4. Katzenstein HM, Krailo MD, Malogolowkin MH, et al. Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer. 2003;97:2006-2012. (Pubitemid 36397279)
5. Pinna AD, Iwatsuki S, Lee RG, et al. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology. 1997;26:877-883. (Pubitemid 27413652)
6. Kakar S, Burgart LJ, Batts KP, et al. Clinicopathologic features and survival in fibrolamellar carcinoma: Comparison with conventional hepatocellular carcinoma with and without cirrhosis. Mod Pathol. 2005;18:1417-1423. (Pubitemid 41509395)
7. Colquhoun AJ, Mellon JK. Epidermal growth factor receptor and bladder cancer. Postgrad Med J. 2002;78:584-589. (Pubitemid 35333063)
8. Buckley AF, Burgart LJ, Sahai V, et al. Epidermal growth factor receptor expression and gene copy number in conventional hepatocellular carcinoma. Am J Clin Pathol. 2008;129: 245-251. (Pubitemid 352029315)
9. Agarwal VR, Takayama K, Van Wyk JJ, et al. Molecular basis of severe gynecomastia associated with aromatase expression in a fibrolamellar hepatocellular carcinoma. J Clin Endocrinol Metab. 1998;1797-1800. (Pubitemid 28501061)
10. Hany MA, Betts DR, Schmugge M, et al. A childhood fibrolamellar hepatocellular carcinoma with increased aromatase activity and a near triploid karyotype. Med Pediatr Oncol. 1997;28:136-138. (Pubitemid 27034289)
11. McCloskey JJ, Germain-Lee EL, Perman JA, et al. Gynecomastia as a presenting sign of fibrolamellar carcinoma of the liver. Pediatrics. 1988;82:379-382.
12. lovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378-390.
13. Smith MT, Blatt ER, Jedlicka P, et al. Best cases from the AFIP: Fibrolamellar hepatocellular carcinoma. Radiographics. 2008;28:609-613.
14. Sher ES, Migeon CJ, Berkovitz GD. Evaluation of boys with marked breast development at puberty. Clin Pediatr (Phila). 1998;37:367-371.
15. Nicholson RI, Gee JM, Harper ME. EGFR and cancer prognosis. Eur J Cancer. 2001;37(suppl 4):S9-S15. (Pubitemid 32938124)
16. Spano JP, Lagorce C, Atlan D, et al. Impact of EGFR expression on colorectal cancer patient prognosis and survival. Ann Oncol. 2005;16:102-108. (Pubitemid 40124486)
17. Buckley AF, Burgart LJ, Kakar S. Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma. Hum Pathol. 2006;37:410-414.
18. Mitchell P. Erbitux diagnostic latest adjunct to cancer therapy. Nat Biotechnol. 2004;22:363-364.
19. Karapetis CS, Khambata-Ford S, Jonker DJ, et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med. 2008;359:1757-1765.
20. Carruba G. Aromatase in nontumoral and malignant human liver tissues and cells. Ann N Y Acad Sci. 2009;1155:187-193.
21. Kawai H, Ishii A, Washiya K, et al. Combined overexpression of EGFR and estrogen receptor alpha correlates with a poor outcome in lung cancer. Anticancer Res. 2005;25:4693-4698. (Pubitemid 41729532)